Real-time enrollment status for this meningioma clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 6:20 PM UTC
| NCT Number | NCT07533942 |
| Recruiting Status | Recruiting |
| Condition | Meningioma |
| Phase | PHASE2 |
| Target Enrollment | 30 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Jazz Pharmaceuticals |
| Last Updated on CT.gov | July 30, 2026 (4 weeks ago) |
As of August 28, 2026: Clinical trial NCT07533942 is currently recruiting participants. This phase2 study for meningioma is actively seeking new participants at 5 locations across the United States. The study is sponsored by Jazz Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07533942 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07533942 was last updated 4 weeks ago (July 30, 2026). HelloStudys verifies this status automatically.